ESR1 and neoplasm: There was no evidence of heterogeneity in the associations of total and free testosterone with breast cancer risk in subgroups according to tumor type, estrogen receptor status, age and BMI at enrollment, menopausal status at diagnosis and lag time between blood donation and diagnosis.